1. Home
  2. ZLAB vs ASPN Comparison

ZLAB vs ASPN Comparison

Compare ZLAB & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • ASPN
  • Stock Information
  • Founded
  • ZLAB 2013
  • ASPN 2001
  • Country
  • ZLAB China
  • ASPN United States
  • Employees
  • ZLAB N/A
  • ASPN N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • ASPN RETAIL: Building Materials
  • Sector
  • ZLAB Health Care
  • ASPN Consumer Discretionary
  • Exchange
  • ZLAB Nasdaq
  • ASPN Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • ASPN 486.5M
  • IPO Year
  • ZLAB 2017
  • ASPN 2014
  • Fundamental
  • Price
  • ZLAB $36.40
  • ASPN $6.40
  • Analyst Decision
  • ZLAB Buy
  • ASPN Strong Buy
  • Analyst Count
  • ZLAB 5
  • ASPN 10
  • Target Price
  • ZLAB $54.28
  • ASPN $21.78
  • AVG Volume (30 Days)
  • ZLAB 886.5K
  • ASPN 1.4M
  • Earning Date
  • ZLAB 08-05-2025
  • ASPN 08-06-2025
  • Dividend Yield
  • ZLAB N/A
  • ASPN N/A
  • EPS Growth
  • ZLAB N/A
  • ASPN N/A
  • EPS
  • ZLAB N/A
  • ASPN N/A
  • Revenue
  • ZLAB $418,326,000.00
  • ASPN $436,921,000.00
  • Revenue This Year
  • ZLAB $44.07
  • ASPN N/A
  • Revenue Next Year
  • ZLAB $49.13
  • ASPN $24.31
  • P/E Ratio
  • ZLAB N/A
  • ASPN N/A
  • Revenue Growth
  • ZLAB 43.72
  • ASPN 51.90
  • 52 Week Low
  • ZLAB $16.01
  • ASPN $4.16
  • 52 Week High
  • ZLAB $44.34
  • ASPN $33.15
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 52.67
  • ASPN 57.67
  • Support Level
  • ZLAB $34.79
  • ASPN $5.75
  • Resistance Level
  • ZLAB $36.73
  • ASPN $6.21
  • Average True Range (ATR)
  • ZLAB 1.23
  • ASPN 0.32
  • MACD
  • ZLAB -0.46
  • ASPN 0.03
  • Stochastic Oscillator
  • ZLAB 25.91
  • ASPN 86.93

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

Share on Social Networks: